BIAF · bioAffinity Technologies, Inc. · Webcasts, Transcripts & Audio
$1.76
-0.09 (-4.86%)
At close · Nov 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current expected level of operating expenditures, current expected levels of revenue, and the cash and cash equivalents on hand at September 30, 2026, of $2.6 million, management concludes that there is substantial doubt about our ability to continue as a going concern for a period of at least twelve (12) months subsequent to the issuance of the accompanying unaudited condensed consolidated financial statements contained in this Quarterly Report.”View the 10-Q filed Nov 6, 2026
Market Cap
$3.37M
Shares
1.82M
Volume · Nov 20
16.77K
Avg daily vol (63 sessions)
3.6M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
bioAffinity Technologies, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for bioAffinity Technologies, Inc. (BIAF), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY23 · Q1
2023-05-15
bioAffinity Technologies, Inc. (BIAF) Q1 2023 Earnings Call
Revenue
$1.81M
Diluted EPS
$-81.00
Gross margin
0.0%
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-04-03
bioAffinity Technologies, Inc. (BIAF) Q4 2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–2 of 2 webcasts
Key facts
CIK
1712762
CUSIP
09076W406
13F (30d)
21 filings
14 filers
Visit website
Investor relations